What We Do


Obesity is a chronic disease and a leading cause of diabetes, heart disease, certain cancers and other serious health problems in the United States, with about a third of the population affected. According to the Centers for Disease Control and Prevention, as of 2008, the medical costs associated with obesity were estimated at $147 billion; the medical costs paid by third-party payers for people who are obese were $1,429 higher than those of normal weight.

Obesity is linked to the bodies' ability to regulate food intake and control appetite. These vital functions are controlled in a large part by chemical messengers called neurotransmitters.  The production of these neurotransmitters depends heavily on the availability and metabolism of certain amino acids and nutrients which are often absent or deficient in obese individuals.

Weight gain and obesity are common outcomes of inappropriate responses to appetite cues, satiety signals, and uncontrolled cravings for energy-dense foods. Addressing the increased nutritional requirements of obese individuals with specific amino acid based medical foods can restore the chemical balance responsible for regulating appetite and satiety, helping to safely and effectively reduce appetite and manage obesity.

Traditional approaches to appetite control have for the most part been unsuccessful in changing eating behavior. Many of the proposed treatments, particularly pharmaceutical agents, have significant side effects including death and serious heart valve disease. Medical foods have been used for the dietary management of obesity for over a decade without any reported adverse side effects and offer both patients and physicians a safe and effective therapeutic option managing appetite by addressing the increased nutritional requirements of obesity.